A food allergy is an immune system reaction where the body wrongly identifies certain food proteins as threats, triggering symptoms that can range from mild (hives, itching) to severe (anaphylaxis). Food allergies affect millions globally and can be life-threatening. They require constant vigilance and reliable treatments, making effective diagnostics and therapies critical for public health and safety.
According to BIS Research, global food allergy is set to grow substantially in the next 10 years.
Explore the Full TOC and Download Report Sample >>
The global food allergy market is undergoing a significant transformation, driven by rising allergy prevalence, growing public awareness, and advancements in diagnostics and therapeutics. As the industry shifts from reactive symptom management to proactive, preventive approaches like immunotherapy and biologics, investment and innovation continue to accelerate. While challenges such as diagnostic limitations, testing delays, and treatment risks remain, increasing R&D focus and supportive healthcare infrastructure are paving the way for more effective and accessible allergy care. With strong demand across regions, especially in North America; the market is well-positioned for sustained growth through 2035.
-BIS Research Analyst Team
Discover BIS Research Surgical Procedure Volume Database – your key to real-world, country-level procedural insights across MedTech.
Leading players are advancing oral immunotherapies and biologics while prioritizing more accurate, early-stage diagnostic solutions to improve food allergy management.
North America holds the largest share in the global food allergy market, with the U.S. being a major contributor.
The most in-demand technologies in the food allergy market include oral immunotherapy, biologics, advanced diagnostic tools, and genetically engineered desensitization therapies.
BIS Research offers KOL-based insights, rigorous segmentation, and strategic advisory across software, hardware, and sensing tech domains.
